(Q22305826)

16 June 2018

review article

1 reference

title

Diagnosis and Treatment of Agoraphobia with Panic Disorder (English)

1 reference

16 June 2018

0 references

1 reference

Giulio Perugi

1

Giulio

Perugi

1 reference

16 June 2018

Franco Frare

series ordinal

2

author given names

Franco

author last names

Frare

1 reference

16 June 2018

Cristina Toni

series ordinal

3

author given names

Cristina

author last names

Toni

1 reference

16 June 2018

publication date

1 January 2007

1 reference

16 June 2018

published in

CNS Drugs

1 reference

16 June 2018

volume

21

1 reference

16 June 2018

page(s)

741-764

1 reference

16 June 2018

issue

9

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.2165/00023210-200721090-00004

exact match

0 references

cites work

Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Irritable bowel syndrome and psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Prevalence of psychiatric disorders in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Recognition, management, and course of anxiety and depression in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Imipramine in the treatment of agoraphobia: dose-response relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721090-00004

Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment

21 January 2018

1 reference

12 December 2020

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

1 reference

12 December 2020

Psychiatric disorder and functional somatic symptoms as predictors of health care use

1 reference

12 December 2020

Panic disorder: residual symptoms after the acute attacks abate.

1 reference

12 December 2020

Clonazepam: new uses and potential problems

1 reference

12 December 2020

Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies.

1 reference

12 December 2020

One-year follow-up of panic disorder. Outcome and prognostic factors.

1 reference

12 December 2020

Agoraphobia: a Follow-up Study Four Years After Treatment

1 reference

12 December 2020

Frustrating patients: physician and patient perspectives among distressed high users of medical services.

1 reference

12 December 2020

Axis I disorders in ER patients with atypical chest pain

1 reference

12 December 2020

Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder

1 reference

12 December 2020

Sleep in patients with spontaneous panic attacks.

1 reference

12 December 2020

A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

1 reference

12 December 2020

Fresh Symptom Emergence After Intensive Behaviour Therapy

1 reference

12 December 2020

Early coadministration of clonazepam with sertraline for panic disorder

1 reference

12 December 2020

DSM-III personality disorder in agoraphobia. II. Changes with treatment

1 reference

12 December 2020

The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication

1 reference

12 December 2020

Maintenance drug therapy of panic disorder

1 reference

12 December 2020

Delineating a putative phobic-anxious temperament in 126 panic-agoraphobic patients: toward a rapprochement of European and US views.

1 reference

12 December 2020

Psychophysiological, somatic, and affective changes across the menstrual cycle in women with panic disorder.

1 reference

12 December 2020

Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders.

1 reference

12 December 2020

A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder

1 reference

12 December 2020

A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants

1 reference

12 December 2020

Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study

1 reference

12 December 2020

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

12 December 2020

Phobic disorders four years after treatment: a prospective follow-up.

1 reference

12 December 2020

Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder

1 reference

12 December 2020

Agoraphobics 5 years after imipramine and exposure. Outcome and predictors

1 reference

12 December 2020

Hypochondriasis and illness phobia in panic-agoraphobic patients.

1 reference

12 December 2020

The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.

1 reference

12 December 2020

Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia

1 reference

12 December 2020

[Panic disorder and alcoholism]

1 reference

12 December 2020

Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial

1 reference

12 December 2020

Emotion-focused psychotherapy for patients with panic disorder.

1 reference

12 December 2020

Lorazepam vs. alprazolam in the treatment of panic disorder

1 reference

12 December 2020

Identifying and treating panic disorder in primary care.

1 reference

12 December 2020

Long-term effects of behavioural treatment for panic disorder with agoraphobia.

1 reference

12 December 2020

Angina as a symptom of psychiatric illness.

1 reference

12 December 2020

Use of health care services by persons with panic symptoms

1 reference

12 December 2020

Predictors of outcome in panic disorder: a 5-year prospective follow-up study

1 reference

12 December 2020

Pretreatment attrition in a comparative treatment outcome study on panic disorder

1 reference

12 December 2020

Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs

1 reference

12 December 2020

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

12 December 2020

Depressive comorbidity of panic, social phobic, and obsessive–compulsive disorders re-examined: is there a bipolar ii connection?

1 reference

12 December 2020

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder

1 reference

12 December 2020

The dependence potential of short half-life benzodiazepines: a meta-analysis

1 reference

12 December 2020

The Galway Study of Panic Disorder. III. Outcome at 5 to 6 years

1 reference

12 December 2020

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

1 reference

12 December 2020

Sertraline treatment of panic disorder: results of a long-term study

1 reference

12 December 2020

An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.

1 reference

12 December 2020

Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.

1 reference

12 December 2020

Emergence of depressive symptoms in patients receiving alprazolam for panic disorder

1 reference

12 December 2020

Panic disorder. Spectrum of severity and somatization.

1 reference

12 December 2020

Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder

1 reference

12 December 2020

Discontinuation reactions to alprazolam in panic disorder

1 reference

12 December 2020

Agoraphobia with panic attacks: 1-year prospective follow-up.

1 reference

12 December 2020

A naturalistic 6-year follow-up study of patients with panic disorder

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment

1 reference

12 December 2020

Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia.

1 reference

12 December 2020

The epidemiology of anxiety and panic disorders: an update

1 reference

12 December 2020

Classification of anxiety disorders: a critique of DSM-III.

1 reference

12 December 2020

Alcohol dependence in panic disorder patients

1 reference

12 December 2020

Panic disorder in pregnancy

1 reference

12 December 2020

Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study

1 reference

12 December 2020

Nocturnal panic: biology, psychopathology, and its contribution to the expression of panic disorder

1 reference

12 December 2020

Fluoxetine in panic disorder.

1 reference

12 December 2020

A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia

1 reference

12 December 2020

SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis

1 reference

12 December 2020

The Zurich Study. IX. Panic disorder and sporadic panic: symptoms, diagnosis, prevalence, and overlap with depression.

1 reference

12 December 2020

Panic disorder: a treatment update

1 reference

12 December 2020

A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety

1 reference

12 December 2020

Two-year follow-up of agoraphobics after exposure and imipramine

1 reference

12 December 2020

A crossover study of focused cognitive therapy for panic disorder

1 reference

12 December 2020

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group

1 reference

12 December 2020

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

1 reference

12 December 2020

Interactive model of therapeutic response in panic disorder: moclobemide, a case in point

1 reference

12 December 2020

Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study

1 reference

12 December 2020

Brief standard self-rating for phobic patients

1 reference

12 December 2020

Controlled comparison of the characteristics of patients with panic disorder

1 reference

12 December 2020

The abrupt discontinuation of fluvoxamine in patients with panic disorder

1 reference

12 December 2020

Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.

1 reference

12 December 2020

Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial

1 reference

12 December 2020

Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety

1 reference

12 December 2020

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

The concept of recovery in affective disorders

1 reference

12 December 2020

Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.

1 reference

12 December 2020

Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder

1 reference

12 December 2020

Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study.

1 reference

12 December 2020

The Mobility Inventory for Agoraphobia.

1 reference

12 December 2020

Effect of fluvoxamine on panic disorder

1 reference

12 December 2020

Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial

1 reference

12 December 2020

Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.

1 reference

12 December 2020

Panic and panic disorder in the United States

1 reference

12 December 2020

A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine

1 reference

12 December 2020

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

1 reference

12 December 2020

Environmental factors related to the outcome of panic disorder. A seven-year follow-up study.

1 reference

12 December 2020

Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment

1 reference

12 December 2020

Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants

1 reference

12 December 2020

Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up

1 reference

12 December 2020

Duration of imipramine therapy and relapse in panic disorder with agoraphobia

1 reference

12 December 2020

A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder

1 reference

12 December 2020

Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.

1 reference

12 December 2020

The classification of phobic disorders

1 reference

12 December 2020

Paroxetine, Clomipramine, and Cognitive Therapy in the Treatment of Panic Disorder

1 reference

12 December 2020

A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care.

1 reference

12 December 2020

Response of panic disorder to fixed doses of alprazolam or imipramine.

1 reference

12 December 2020

Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.

1 reference

12 December 2020

A meta-analysis of treatments for panic disorder

1 reference

12 December 2020

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

12 December 2020

The effect of citalopram in panic disorder

1 reference

12 December 2020

Unemployment and Emergency Room Visits Predict Poor Treatment Outcome in Primary Care Panic Disorder

1 reference

12 December 2020

Psychosensorial and related phenomena in panic disorder and in temporal lobe epilepsy.

1 reference

12 December 2020

Gender differences in panic disorder: findings from the National Comorbidity Survey.

1 reference

12 December 2020

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder

1 reference

12 December 2020

Medication discontinuation in panic disorder.

1 reference

12 December 2020

Long-term pharmacologic treatment of panic disorder

1 reference

12 December 2020

Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review

1 reference

12 December 2020

Panic disorder: long-term pharmacotherapy and discontinuation

1 reference

12 December 2020

1 reference

12 December 2020

Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response

1 reference

12 December 2020

Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse

1 reference

12 December 2020

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Cognitive-behavioral therapy for panic: effectiveness and limitations

1 reference

12 December 2020

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

1 reference

12 December 2020

Substance abuse and panic-related anxiety: a critical review

1 reference

12 December 2020

Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996.

1 reference

12 December 2020

Panic: course, complications and treatment of panic disorder

1 reference

12 December 2020

Agoraphobia: the long-term follow-up of behavioural treatment.

1 reference

12 December 2020

Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.

1 reference

12 December 2020

Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group

1 reference

12 December 2020

Effectiveness of an empirically based treatment for panic disorder delivered in a service clinic setting: 1-year follow-up

1 reference

12 December 2020

DSM-III personality disorders and the outcome of treated panic disorder.

1 reference

12 December 2020

A withdrawal syndrome after abrupt discontinuation of alprazolam

1 reference

12 December 2020

Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review

1 reference

12 December 2020

Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.

1 reference

12 December 2020

Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder

1 reference

12 December 2020

The impact of pregnancy and puerperium on panic disorder: a review

1 reference

12 December 2020

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

12 December 2020

The long-term course of panic disorder--an 11 year follow-up

1 reference

12 December 2020

The effects of pregnancy on preexisting panic disorder

1 reference

12 December 2020

Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.

1 reference

12 December 2020

Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder

1 reference

12 December 2020

Desipramine treatment in panic disorder

1 reference

12 December 2020

5-year prospective, naturalistic follow-up study of panic disorder

1 reference

12 December 2020

Association of road-traffic accidents with benzodiazepine use.

1 reference

12 December 2020

Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder

1 reference

12 December 2020

Prodromal symptoms in panic disorder with agoraphobia.

1 reference

12 December 2020

Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks

1 reference

12 December 2020

Treatment-emergent depression with antidepressants in panic disorder

1 reference

12 December 2020

Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder

1 reference

12 December 2020

Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships

1 reference

12 December 2020

Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?

1 reference

12 December 2020

Diazepam versus alprazolam for the treatment of panic disorder.

1 reference

12 December 2020

Fibrocystic breast disease following treatment with selective serotonin reuptake inhibitors.

1 reference

12 December 2020

Derealization and panic attacks: a clinical evaluation on 150 patients with panic disorder/agoraphobia.

1 reference

12 December 2020

Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder

1 reference

12 December 2020

Impact of pregnancy on panic disorder: a case series

1 reference

12 December 2020

Understanding and treating panic disorder in the primary care setting.

1 reference

12 December 2020

Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors

1 reference

12 December 2020

Subclinical symptoms of panic disorder: new insights into pathophysiology and treatment

1 reference

12 December 2020

Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants

1 reference

12 December 2020

Is premenstrual dysphoria a variant of panic disorder? A review

1 reference

12 December 2020

Two-year follow-up of exposure and imipramine treatment of agoraphobia

1 reference

12 December 2020

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

12 December 2020

A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies.

1 reference

12 December 2020

Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.

1 reference

12 December 2020

Lifetime panic-depression comorbidity in the National Comorbidity Survey

1 reference

12 December 2020

The role of anxiety level, coping styles, and cycle phase in menstrual distress.

1 reference

12 December 2020

An open trial of fluoxetine in the treatment of panic attacks

1 reference

12 December 2020

Generalized anxiety disorder patients seek evaluation for cardiological symptoms at the same frequency as patients with panic disorder

1 reference

12 December 2020

A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments

1 reference

12 December 2020

The quality of care for depressive and anxiety disorders in the United States.

1 reference

12 December 2020

Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment

1 reference

12 December 2020

10.2165/00023210-200721090-00004

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

0 references

1 reference

16 June 2018